Cite

HARVARD Citation

    Nakashima, Y. et al. (2020). Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice. Modern rheumatology. 30 (5), pp. 807-815. [Online]. 
  
Back to record